LONDON – Optima Health plc (AIM: OPT), a leading UK provider of corporate health and wellbeing solutions, disclosed a recent transaction involving a key insider. Joanne Newey, who serves as the Group Business Development & Propositions Director and is a Person Discharging Managerial Responsibilities (PDMR) within the company, purchased 14,046 ordinary shares at a price of 143.14 pence per share on January 17, 2025.
This transaction took place on the London Stock Exchange (LON:)’s AIM market, and following this acquisition, Newey now holds a total of 84,080 ordinary shares. Her stake represents approximately 0.09% of the current issued share capital of Optima Health.
Optima Health has been a prominent player in the occupational health and wellbeing sector for 25 years, offering innovative and tailored solutions to a diverse range of clients. The company emphasizes the importance of a healthy and high-performing workplace, leveraging its clinical expertise to meet the needs of its clients effectively.
The announcement of this insider purchase is a routine disclosure required by market regulations, intended to maintain transparency in financial activities involving company insiders. These disclosures provide investors and the market with insight into the actions of those who hold managerial responsibilities within publicly traded companies.
This information is based on a press release statement from Optima Health plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
